Built on cutting-edge Taqman chemistry, these assays ensure superior sensitivity and specificity, making them a gold standard for decentralized testing.
Ready-to-usePCR reagents.
Taqman-based assays provide exceptional accuracy and reliability.
Requires minimal biosafety infrastructure, enabling safe field deployment.
Embedded batch-specific data enhances result quantitation and traceability.
Specially designed reaction port prevents contamination and evaporation.
Long shelf life, maintaining integrity for up to 2 years at 30°C.
High primer sensitivity and specificity for precise disease detection.
Specially designed reaction port prevents contamination and evaporation.
Long shelf life, maintaining integrity for up to 2 years at 30°C.
Ready-to-use PCR reagents.
Taqman-based assays provide exceptional accuracy and reliability.
Requires minimal biosafety infrastructure, enabling safe field deployment.
Embedded batch-specific data enhances result quantitation and traceability.
Specially designed reaction well prevents contamination and evaporation.
Long shelf life, maintaining integrity for up to 2 years at 30°C.
High primer sensitivity and specificity for precise disease detection.
Needs only 6µL of sample, ensuring minimal sample wastage.
Sample-to-result in one hour (60 minutes), ensuring fast turnaround time.
Truenat® MTB is a chip-based real-time PCR test for quantitative detection and diagnosis of Mycobacterium tuberculosis (MTB) in human pulmonary and EPTB specimens, aiding the diagnosis of tuberculosis.
WHO defines it as the bacterium causing tuberculosis (TB), primarily affecting the lungs but capable of affecting other body parts. A total of 1.25 million people died from TB in 2023 (including 161,000 people with HIV). TB is present in all countries and age groups, but is curable and preventable with timely diagnosis and treatment initiation.
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human pulmonary and EPTB specimen |
| Gene Target | nrdB gene which codes for Truenat® MTB ribonucleoside- diphosphate reductase large subunit |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 100 CFU/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Test pack size | 5T, 25, 50T |
| Test pack size | Cat No |
| 5T | 601030005 |
| 25T | 601030025 |
| 50T | 601030050 |
Trueprep AUTO MTB Sample Pre-treatment Pack
Trueprep AUTO v2 universal cartridge-based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® MTB Plus is a chip-based Real Time PCR Test for semi-quantitative detection and diagnosis of Mycobacterium tuberculosis (MTB) in human pulmonary and EPTB specimens and aids in the diagnosis of infection with MTB.
WHO defines it as the bacterium causing tuberculosis (TB), primarily affecting the lungs but capable of affecting other body parts. While TB can affect all population, people with immunocompromised conditions such as HIV, diabetes, or children and pregnant women can fall sick with TB even with a low load of bacilli. A highly sensitive test that effectively detects the bacteria is crucial in disease response.
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Sputum / Non Sputum / EPTB |
| Gene Target | nrdz gene & IS6110 gene sequence |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 29 cells/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Test pack size | - |
| 5T | 601130005 |
| 25T | 601130025 |
| 50T | 601130050 |
Trueprep AUTO MTB Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® MTB-RIF Dx is a chip-based real-time PCR Test for the detection of Rifampicin resistance in Mycobacterium tuberculosis in Truenat MTB/MTB Plus positive human specimens and aids in the diagnosis of MDR-TB. This test detects the presence of major mutations (SNPs) in the MTB genome that are known to cause resistance to rifampicin.
Rifampicin-resistant tuberculosis (RR-TB) occurs when Mycobacterium tuberculosis strains develop resistance to rifampicin, a critical first-line anti-TB drug. In 2020, nearly half a million individuals worldwide contracted RR-TB, underscoring its significant global health impact.
Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry followed by melt-curve assay |
| Assay type | Qualitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | MTB positive human specimen |
| Gene Target | RRDR region of the rpoB gene |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 96% |
| LOD | 200 cells/mL of Sputum |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601210005 |
| 20T | 601210020 |
| 25T | 601210025 |
| 50T | 601210050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® MTB-INH is a chip-based Real Time PCR test for detection of Isoniazid resistance in Mycobacterium tuberculosis (MTB) in Truenat MTB/MTB Plus positive human specimen and aids in the diagnosis of MDR-TB. This test detects the presence of major mutations (SNPs) in the MTB genome that are known to cause resistance to Isoniazid.
Isoniazid-resistant tuberculosis (INH-resistant TB) occurs when Mycobacterium tuberculosis develops resistance to isoniazid, a key drug used in the treatment of TB. Globally, INH resistance is a significant issue, with data showing that around 10-20% of multidrug-resistant TB (MDR-TB) cases also exhibit resistance to isoniazid. An effective drug susceptibility test for INH resistance is crucial for informed clinical decisions.
Highest prevalence in
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry followed by melt-curve assay |
| Assay type | Qualitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | MTB positive human specimen |
| Gene Target | inhA and katG genes of Mycobacterium tuberculosis genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 96% |
| LOD | 494 cells/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601360005 |
| 20T | 601360020 |
| 25T | 601360025 |
| 50T | 601360050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Influenza A/B is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of Influenza A and Influenza B virus in human throat and nasal swab specimens and aids in differential diagnosis of infection with Influenza A and/or Influenza B virus.
A viral infection affecting the respiratory tract, there are around a billion cases of seasonal influenza annually, including 3–5 million cases of severe illness. With 290,000 to 650,000 respiratory deaths annually, ninety-nine percent of deaths are in children under 5 years of age, mostly in developing countries.
Global distribution with seasonal patterns:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human throat and nasal swab specimens |
| Gene Target | M gene of Influenza A and NSP gene of Influenza B genome |
| Internal Controls | Internal Process Control - Extraction Control |
| LOD | 810.15 copies/ml for Inf A, 755.21 copies/ml for Inf B |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601200005 |
| 20T | 601200020 |
| 25T | 601200025 |
| 50T | 601200050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® H3N2/H1N1 is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of H3N2 and H1N1 virus in human throat and nasal swab specimens and aids in differential diagnosis of infections with H3N2 and/or H1N1 virus.
H3N2 and H1N1 are subtypes of the Influenza A virus, both known to cause seasonal flu outbreaks. H3N2, a subtype of Influenza A, is known for its ability to evolve rapidly, making it a significant cause of flu-related illnesses, particularly in older adults and individuals with underlying health conditions. H1N1 caused the 2009 “swine flu” pandemic, resulting in an estimated 284,400 deaths worldwide.
Worldwide impact with particular severity in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 70 minutes (samle to result) |
| Clinical Specimen | Oropharyngeal/ Nasopharyngeal swab |
| Gene Target | Conserved sequences of swine influenza A virus (swInfA) nucleocapsid gene, the H1N1 swine influenza A virus (swH1) hemagglutinin gene |
| Internal Controls | Human RNase P gene - full process internal positive control (IPC) for swab collection, |
| Sensitivity | 100% |
| Specificity | 99% |
| LOD | 873.02 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601310005 |
| 20T | 601310020 |
| 25T | 601310025 |
| 50T | 601310050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® COVID-19 is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of SARS CoV-2 RNA in human oropharyngeal and nasopharyngeal swab specimen and aids in detection and confirmation of SARS CoV-2 infection and diagnosis of COVID-19. The test detects the E and Orf1a genes of the virus.
COVID-19, caused by the SARS-CoV-2 virus, primarily affects the respiratory system. It emerged in late 2019 and rapidly evolved into a global pandemic causing more than 6.88 million deaths worldwide.
Global pandemic affecting all countries, with particular impact on:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human oropharyngeal and nasopharyngeal swab specimen |
| Gene Target | E and Orf1a gene |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | Orf1a: 480 genome copies/mL, E gene: 487 genome copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601430005 |
| 20T | 601430020 |
| 25T | 601430025 |
| 50T | 601430050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Inf A, B/COVID-19 is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of InfluenzaA,B and COVID-19 in human oropharyngeal and nasopharyngeal swab specimen and aids in the differenetial diagnosis of infection with Influenza A,B and COVID-19 virus.
WHO defines these as viral infections affecting the respiratory tract. Influenza A can infect humans and animals, while Influenza B primarily affects humans.
Burden: Global distribution with seasonal patterns:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human oropharyngeal and nasopharyngeal swab specimens |
| Gene Target | Orf1a gene and RdRP gene for COVID-19. For Influenza A it is gene coding for matrix protein and for Influenza B it is gene coding for nonstructural protein. |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | LoD for Inf A, Inf B and COVID-19 was estimated to be 887.42, 786.20 and 493.66 genome copies/ml respectively |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601720005 |
| 20T | 601720020 |
| 25T | 601720025 |
| 50T | 601720050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO Transport Medium for Swab Specimen Pack
Trueprep AUTO v2 Universal Cartridge Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
A chip-based real-time duplex PCR test for the quantitative detection of Plasmodium vivax and Plasmodium falciparum in blood specimens, aiding malaria diagnosis.
Malaria, with over 200 million cases annually, remains a major global health threat, especially in tropical and subtropical regions like sub-Saharan Africa, Southeast Asia, and parts of Latin America. Caused by Plasmodium parasites transmitted by Anopheles mosquitoes, it poses a diagnostic challenge due to low parasite loads, often leading to false negatives with traditional methods. PCR-based molecular tests offer higher sensitivity, enabling more accurate detection, early diagnosis, and timely interventions, especially in regions with low but ongoing transmission.
Most heavily impacts tropical and sub-tropical regions, particularly:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood specimen |
| Gene Target | The erythrocyte binding protein (EBP) gene which is expressed on the surface of the merozoites |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 1553 copies/mL for Plasmodium falciparum plasmid DNA and 2569 copies/mL for Plasmodium vivax plasmid DNA. |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Test pack size | Catalog No. |
| 5 Tests | 601010005 |
| 25T | 601010025 |
| 50T | 601010050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Dengue/Chikungunya is a chip-based real-time duplex PCR test for the quantitative detection of dengue and chikungunya viruses in blood/serum/plasma, aiding in their differential diagnosis.
A viral infection causing severe flu-like illness, the WHO defines it as a fast-emerging pandemic-prone viral disease transmitted by Aedes mosquitoes. With an estimated 100–400 million infections occurring each year, half of the world’s population is now at risk of dengue. While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Most heavily impacts tropical and sub-tropical regions, particularly:
Chikungunya, transmitted by mosquitoes in Africa, Asia, and the Americas, causes fever and severe joint pain. Its symptoms resemble those of dengue and Zika, making misdiagnosis common. This highlights the need for more accurate molecular tests for proper diagnosis.
Predominantly affects:
| Test Name | Truenat® Dengue/Chikungunya |
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/plasma/serum specimens |
| Gene Target | Part of 3' untranslated region (UTR) of the dengue genome and Non-structural protein 4(nsP4) gene of the Chikungunya genome |
| Internal Controls | Internal Process Control - Extraction Control |
| LOD | 139.76 copies/mL for Dengue; 180.45 copies/mL for Chikungunya |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601040005 |
| 20T | 601040020 |
| 25T | 601040025 |
| 50T | 601040050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Dengue is a chip-based real-time PCR test for quantitative detection of dengue virus in human blood/serum/plasma specimens and aiding diagnosis of dengue disease.
A viral infection causing severe flu-like illness, the WHO defines it as a fast-emerging pandemic-prone viral disease transmitted by Aedes mosquitoes. With an estimated 100–400 million infections occurring each year, half of the world’s population is now at risk of dengue. While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Most heavily impacts tropical and sub-tropical regions, particularly:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/plasma/serum specimens |
| Gene Target | Part of 3' untranslated region (UTR) of the dengue genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 222.99 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601050005 |
| 20T | 601050020 |
| 25T | 601050025 |
| 50T | 601050050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Chikungunya is a chip-based Real Time PCR Test for quantitative detection of Chikungunya virus in human blood/serum/plasma specimen and aids in the diagnosis of infection with Chikungunya
Chikungunya, transmitted by mosquitoes in Africa, Asia, and the Americas, causes fever and severe joint pain. Its symptoms resemble those of dengue and Zika, making misdiagnosis common. This highlights the need for more accurate molecular tests for proper diagnosis.
Predominantly affects:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/plasma/serum specimens |
| Gene Target | Non-structural protein 4(nsP4) gene of the Chikungunya genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 10 copies of RNA/reaction |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601060005 |
| 20T | 601060020 |
| 25T | 601060025 |
| 50T | 601060050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HBV is a chip-based Real Time PCR Test for quantitative estimation of the Hepatitis B Virus (HBV) in human blood/serum/plasma specimen and aids in the diagnosis of infection with Hepatitis B virus and in the estimation of viral load.
Hepatitis B is a viral infection that attacks the liver and can cause acute or chronic disease. WHO estimates that 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new infections each year. It spreads through contact with infected blood, semen, or bodily fluids, often via unprotected sex, needle sharing, or from mother to child. While many recover from acute infection, chronic hepatitis B can lead to liver damage, cirrhosis, or liver cancer. Vaccination is highly effective, and antiviral treatments help manage chronic cases. Regular screening is essential for early detection and prevention of complications.
Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/serum/plasma specimen |
| Gene Target | Part of the core/pre-core region of HBV genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 55.92 IU/ml |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601090005 |
| 20T | 601090020 |
| 25T | 601090025 |
| 50T | 601090050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HCV is a chip-based Real Time PCR Test for quantitative detection and the diagnosis of Hepatitis C virus (HCV) in whole blood/plasma/serum and aids in the monitoring of HCV viral load of patients with HCV infection
Hepatitis C is a blood-borne virus causing liver inflammation, transmitted through exposure to blood from unsafe injection practices, unsafe health care, unscreened blood transfusions, injection drug use and sexual practices. Globally, an estimated 50 million people have chronic hepatitis C virus infection, with about 1.0 million new infections occurring per year. Direct-acting antiviral medicines (DAAs) can cure more than 95% of persons with hepatitis C infection, provided access to timely diagnosis and treatment.
Most affected regions:
| Assay Method | Real Time PCR based on Taqman chemistr |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Whole (venous) blood/plasma/serum |
| Gene Target | 3' UTR region of the HCV genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | Genotype and sample specific - consult IFU |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601180005 |
| 20T | 601180020 |
| 25T | 601180025 |
| 50T | 601180050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HAV is a chip-based Real Time PCR Test for quantitative detection and diagnosis of Hepatitis A virus in human blood /serum/ plasma specimen and aids in the diagnosis of infection with Hepatitis A Virus. This test is also intended for qualitative detection and diagnosis of Hepatitis A Virus in Stool sample.
Hepatitis A is an inflammation of the liver that can cause mild to severe illness. The hepatitis A virus (HAV) is transmitted through ingestion of contaminated food and water or through direct contact with an infectious person. In low- and middle-income countries with poor sanitation and hygiene, hepatitis A infection is common, and by the age of 10, about 90% of children have been exposed to the virus.
Highest impact in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection (For blood/serum/plasma) |
| Qualitative detection (For stool) | |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Whole blood/plasma/serum, stool |
| Gene Target | 5’NCR of HAV genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 87.7 IU/mL of Plasma |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601320005 |
| 20T | 601320020 |
| 25T | 601320025 |
| 50T | 601320050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HEV is a chip-based Real Time PCR Test for quantitative detection and diagnosis of Hepatitis E virus in human blood /serum/ plasma specimen and aids in the diagnosis of infection with Hepatitis E Virus. This test is also intended for qualitative detection and diagnosis of Hepatitis E Virus in Stool sample.
Hepatitis E virus (HEV) is a liver infection primarily transmitted through the fecal-oral route, often due to contaminated water or food. It is particularly prevalent in regions with poor sanitation and inadequate access to clean water, such as parts of Asia, Africa, and the Middle East. While most HEV infections are self-limiting and resolve within a few weeks, the virus can cause severe complications in pregnant women, potentially leading to acute liver failure and a high mortality rate. HEV is less likely to cause chronic infection compared to other hepatitis viruses, but it remains a significant public health concern in endemic areas.
Most prevalent in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection (For blood/serum/plasma) |
| Qualitative detection (For stool) | |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Whole blood/plasma/serum, stool |
| Gene Target | ORF 1 poly protein gene of HEV genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 516 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601330005 |
| 20T | 601330020 |
| 25T | 601330025 |
| 50T | 601330050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HIV-1/HIV-2 is a chip-based Real Time Duplex PCR Test for quantitative detection and differential diagnosis of infection with human immunodeficiency virus type 1 & 2 (HIV-1 & 2) in whole blood/plasma/serum and aids in the monitoring of the HIV-1 & 2 viral loads in patients with HIV-1 and/or HIV-2 infection.
HIV-1 and HIV-2 are two distinct types of the human immunodeficiency virus that cause acquired immunodeficiency syndrome (AIDS). HIV-1 is the most widespread strain globally, responsible for the majority of HIV infections. HIV-2, primarily found in West Africa, is less transmissible and generally progresses more slowly than HIV-1. Timely diagnosis and treatment initiation with anti-retroviral therapy can prevent transmission of the infection as well as opportunistic infections.
Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Plasma |
| Gene Target | Pol gene for HIV-1 and 5’ UTR for HIV-2 genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | HIV-1: 635 IU/mL, HIV-2: 1372.80 IU/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601540005 |
| 20T | 601540020 |
| 25T | 601540025 |
| 50T | 601540050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HPV-HR is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of high risk Human Papillomavirus (HPV) types 16, 18, 31 and 45 in female cervical specimens collected by a clinician. It aids in the differential diagnosis of symptomatic or asymptomatic infection with high risk HPV types 16, 31 and 18, 45.
Cervical cancer is one of the most common cancers in the world. Human papillomavirus (HPV) high-risk (HR) types, particularly HPV-16 and HPV-18, are responsible for the majority of cervical cancers worldwide. They are also linked to other cancers, including those of the anus, oropharynx, vulva, and penis. With over 600,000 new cases of cervical cancer diagnosed annually, HPV-HR remains a major public health concern, especially in low- and middle-income countries where screening and vaccination programs are limited.
Global presence with highest impact in:Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Female cervical specimens |
| Gene Target | Regions within the E6 and E7 genes of high |
| risk HPV types 16,18,31 and 45 | |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 97.70% |
| Specificity | 98.90% |
| LOD | 242.86 IU/mL for HPV 16 DNA, 277.44 IU/mL for HPV 18 DNA, 400.94 copies/ml for HPV 31 DNA, and 294.49 IU/mL HPV 45 DNA |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601220005 |
| 20T | 601220020 |
| 25T | 601220020 |
| 50T | 601220020 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HSV 1/2 is a chip-based Real Time PCR Test for semi-quantitative detection of HSV 1/2 virus in genital swab/CSF specimens and aids in the diagnosis of infection with HSV 1/2 virus.
According to the World Health Organization (WHO), Herpes Simplex Virus (HSV) is a prevalent viral infection characterized by two primary types: HSV-1 and HSV-2. While these are chronic, lifelong viral infections that primarily affect the oral and genital regions, causing periodic outbreaks of painful blisters or ulcers, timely diagnosis and antiviral treatments can help manage symptoms, reduce the frequency of outbreaks, and lower the risk of transmission.
Extensive worldwide distribution with the highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Genital swab/CSF specimens |
| Gene Target | DNA Polymerase (UL30) gene of Herpes simplex virus type 1 & 2 genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 294 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601570005 |
| 20T | 601570020 |
| 25T | 601570025 |
| 50T | 601570050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® CT/NG is a chip-based Real Time Duplex PCR Test for semi-quantitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female endocervical and vaginal swab specimens, male urethral swab specimen and male and female urine specimen and aids in the diagnosis of symptomatic or asymptomatic infection with Chlamydia trachomatis and/or Neisseria gonorrhoeae.
Chlamydia trachomatis is the most common STI worldwide, often presenting with mild or no symptoms. If untreated, it can cause complications like pelvic inflammatory disease (PID) and infertility in both men and women, as well as conjunctivitis and trachoma, a major cause of blindness in developing countries. Easily treatable with antibiotics, regular screening—especially for sexually active individuals under 25—is crucial to prevent long-term health issues.
Widespread globally with highest rates in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Female endocervical and vaginal swab specimens, male urethral swab specimen and male and female urine specimen |
| Gene Target | For Chlamydia trachomatis assay, the target is a region within the cryptic plasmid DNA and ompA gene. For Neisseria gonorrhoeae assay, the target is porB gene and opaE gen |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 274.67 copies/mL for Chlamydia trachomatis; 264.65 copies/mL for Neisseria gonorrhoeae |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601160005 |
| 20T | 601160020 |
| 25T | 601160025 |
| 50T | 601160050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Trich is a chip-based Real Time PCR Test for semi-quantitative detection of Trichomonas vaginalis in female endocervical and vaginal swab specimens, male urethral swab specimen and male and female urine specimen and aids in the diagnosis of symptomatic or asymptomatic infection with Trichomonas vaginalis.
Definition: Trichomonas vaginalis, a protozoan parasite causing trichomoniasis, is a common non-viral sexually transmitted infection (STI) worldwide. While many infections are asymptomatic, untreated trichomoniasis can lead to complications such as pelvic inflammatory disease (PID) in women and increased susceptibility to HIV. A treatable and curable condition, regular screening in sexually active individuals is important to prevent transmission and health complications.
Most significantly impacts:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Female endocervical and vaginal swab specimens, male urethral swab specimen and male and female urine specimen |
| Gene Target | Malate dehydrogenase in the T. vaginalis genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 95.83% |
| Specificity | 100% |
| LOD | 246.17 copies/ml |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601050005 |
| 20T | 601050020 |
| 25T | 601050025 |
| 50T | 601050050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Rabies is a chip-based Real Time PCR Test for semi-quantitative detection of Rabies Virus in Cerebrospinal fluid (CSF), saliva, brain tissue, corneal swabs specimens of animals and aids in the diagnosis of Rabies virus
WHO defines it as a viral infection transmitted through animal bites, almost always fatal once symptoms appear.
Highest risk in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Cerebrospinal fluid (CSF), saliva, brain tissue, corneal swabs specimens of animals |
| Gene Target | Nucleoprotein gene of the Rabies genome |
| Internal Controls | Internal Process Control - Extraction Control |
| LOD | 87.7 IU/mL of Plasma |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601120005 |
| 20T | 601120020 |
| 25T | 601120025 |
| 50T | 601120050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Nipah is a chip-based Real Time PCR test for semiquantitative detection and the diagnosis of Nipah virus in Oropharyngeal swab and aids in the diagnosis of infection with Nipah virus RNA.
Definition: WHO defines it as a zoonotic virus causing severe respiratory illness and encephalitis, transmitted by fruit bats and through human-to-human contact.
Outbreaks concentrated in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Oropharyngeal swab specimen |
| Gene Target | Nucleocaspid protein gene |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601390005 |
| 20T | 601390020 |
| 25T | 601390025 |
| 50T | 601390050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® EBV is a chip-based Real Time PCR test for the quantitative detection of Epstein-Barr virus in human blood/serum/plasma and CSF specimens and aids in diagnosis of EBV infection.
Definition: WHO recognizes it as a herpes virus causing infectious mononucleosis and associated with certain cancers.
Worldwide distribution with variations in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/serum/plasma and CSF specimens |
| Gene Target | LMP2 gene of Epstein-Barr virus genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 209 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601600005 |
| 20T | 601600020 |
| 25T | 601600025 |
| 50T | 601600050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® CMV is a chip-based Real Time PCR test for the quantitative detection of Cytomegalovirus in human plasma /whole blood specimens and aids in diagnosis of infection with Cytomegalovirus.
Definition: WHO defines it as a common virus that can cause serious disease in immunocompromised individuals and congenital infections.
Global presence with higher impact in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/serum/plasma specimens |
| Gene Target | UL55 or gB gene coding for |
| envelope glycoprotein B and RL11 gene coding for membrane glycoprotein RL11 | |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 226.79 IU/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601590005 |
| 20T | 601590020 |
| 25T | 601590025 |
| 50T | 601590050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Salmonella is a chip-based Real Time PCR Test for qualitative detection and diagnosis of Salmonella in human blood and aids in the diagnosis of infection with Salmonella.
Salmonella is 1 of 4 key global causes of diarrhoeal diseases. While Most cases of salmonellosis are mild; however, sometimes it can be life-threatening. The severity of the disease depends on host factors and the serotype of Salmonella.
Antimicrobial resistance is a global public health concern and Salmonella is one of the microorganisms in which some resistant serotypes have emerged, affecting the food chain.
WHO defines it as bacteria causing food-borne illness, typically resulting in gastroenteritis but sometimes more severe systemic infections.
Worldwide distribution with highest impact in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Qualitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood |
| Gene Target | pmp' gene encoding the “Plasmid maintenance protein” |
| Internal Controls | Internal Process Control - Extraction Control |
| LOD | 417 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601080005 |
| 20T | 601080020 |
| 25T | 601080025 |
| 50T | 601080050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® GBS is a chip-based Real Time PCR test for semi-quantitative detection and diagnosis of group B streptococcus in vagino-rectal swabs, cerebrospinal fluid (CSF) and Blood/Serum/Plasma specimen and aids in the diagnosis of infection with group B streptococcus.
Group B streptococcus (GBS) is found in up to 35% of healthy women’s reproductive or gastrointestinal tracts. Pregnant women colonized with GBS can transmit the bacteria to their newborns during birth, leading to neonatal sepsis, meningitis, and other complications. GBS is also linked to maternal sepsis, stillbirths, preterm births, and can affect immunocompromised adults and the elderly. However, the highest incidence occurs in neonates and infants up to 3 months. Screening and understanding GBS infections’ clinical presentations and treatments are essential.
Significant impact in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Vagino-rectal swabs, cerebrospinal fluid (CSF) and Blood/Serum/Plasma |
| Gene Target | cAMP factor gene |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | |
| Specificity | |
| LOD | 686.21 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601240005 |
| 20T | 601240020 |
| 25T | 601240025 |
| 50T | 601240050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® LTS is a chip-based Real Time PCR Test for semi quantitative detection of Leptospira and aids in the diagnosis of Leptospirosis in human Blood/Serum/Plasma,cerebrospinal fluid (CSF) and urine specimen.
WHO defines it as bacteria causing leptospirosis, transmitted through contact with water or soil contaminated by infected animal urine.
Highest prevalence in
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood/serum/plasma, CSF, and urine specimen |
| Gene Target | Repetitive elements present across genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 736.62 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601400005 |
| 20T | 601400020 |
| 25T | 601400025 |
| 50T | 601400050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab QuattroTrueprep AUTO v2
Truenat® Scrub T is a chip-based Real Time PCR Test for quantitative detection of Scrub typhus bacteria in blood / Serum / Plasma specimens.Truenat® LTS is a chip-based Real Time PCR Test for semi quantitative detection of Leptospira and aids in the diagnosis of Leptospirosis in human Blood/Serum/Plasma,cerebrospinal fluid (CSF) and urine specimen.
WHO defines it as a mite-borne disease caused by Orientia tsutsugamushi, causing fever and potential organ failure.
Primarily affects:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Whole blood/plasma/serum specimen |
| Gene Target | htrA gene of Orientia tsutsugamushi |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 339 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601450005 |
| 20T | 601450020 |
| 25T | 601450025 |
| 50T | 601450050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Shigella is a chip-based Real Time PCR Test for semi quantitative detection of Shigella spp. in human stool specimen and aids in the diagnosis of infection with Shigella.
Shigellosis, caused by Shigella bacteria, is a leading cause of diarrheal disease and bacillary dysentery, especially in low- and middle-income countries, with an estimated 270 million cases annually. In 2016, Shigella was the second-leading cause of diarrheal mortality, responsible for 212,000 deaths, or 13% of all diarrhea-related deaths, primarily affecting children under 5 in LMICs. Treatment includes antimicrobials, but the rise of antimicrobial resistance (AMR) complicates management increasing morbidity and mortality.
Highest impact in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human stool specimen |
| Gene Target | ipgF gene producing invasion associated protein of Shigella genome |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 413.88 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601470005 |
| 20T | 601470020 |
| 25T | 601470025 |
| 50T | 601470050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® CDI is a chip-based Real Time PCR Test for semi-quantitative detection and diagnosis of Clostridium difficile infections in stool samples.
WHO recognizes it as a bacterium causing severe diarrhea, often associated with antibiotic use and healthcare settings.
Most prevalent in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human stool specimen |
| Gene Target | Gene Clostridium difficile toxin B protein |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | |
| Specificity | |
| LOD | 625.78 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601620005 |
| 20T | 601620020 |
| 25T | 601620025 |
| 50T | 601620050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® Cholera is a chip-based Real Time PCR Test for semi-quantitative detection of Vibrio cholerae in stool sample specimens and aids in the diagnosis of Cholera infections.
A severe diarrheal disease, cholera can be fatal within hours if not treated. Researchers estimate that there are 1.3 to 4.0 million cases and 21 000 to 143 000 deaths from cholera worldwide each year. Effective management with rehydration therapy and antibiotics can save lives provided timely and accurate diagnosis.
Highest risk in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detectio |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human stool |
| Gene Target | Cholera Enterotoxin |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 254.92 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601500005 |
| 20T | 601500020 |
| 25T | 601500025 |
| 50T | 601500050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® M. leprae is a chip-based Real Time PCR Test for the semi-quantitative detection of Mycobacterium leprae in slit skin smear specimens.
Leprosy is a chronic infectious disease caused by Mycobacterium leprae that mainly affects the skin and peripheral nerves. If untreated, it can lead to permanent disabilities. The bacteria spread through respiratory droplets from close contact with untreated cases. Leprosy is curable with access to timely diagnosis and treatment with multidrug therapy (MDT).
Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Semi-quantitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Slit skin smear specimen |
| Gene Target | 16S ribosomal RNA gene, sodA gene, and gene coding for RLEP region |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| LOD | 330 copies/mL |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601700005 |
| 20T | 601700020 |
| 25T | 601700025 |
| 50T | 601700050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Truenat® HLA-B27 is a chip-based Real-Time PCR Test for qualitative detection of HLA-B27 in human blood specimens and aids in diagnosing HLA-B27 typing.
While not a pathogen, WHO recognizes it as a genetic marker strongly associated with certain autoimmune conditions, particularly ankylosing spondylitis.
Highest prevalence in:
| Extraction Method | Microfluidics Cartridge Based Automated in Trueprep AUTO v2 |
| Assay Method | Real Time PCR based on Taqman chemistry |
| Assay type | Qualitative detection |
| Total Assay Time | 60 minutes |
| Clinical Specimen | Human blood |
| Gene Target | Exon 2 of HLA-B |
| Internal Controls | Internal Process Control - Extraction Control |
| Sensitivity | 100% |
| Specificity | 100% |
| Kit Storage Temperature | 2-30℃ |
Each individually sealed pouch contains
| Pack Size | Cat. No. |
| 5T | 601380005 |
| 20T | 601380020 |
| 25T | 601380025 |
| 50T | 601380050 |
Trueprep AUTO Universal Sample Pre-treatment Pack
Trueprep AUTO v2 Universal Cartridge-Based Sample Prep Kit
Trueprep AUTO v2
Truelab Uno Dx/Truelab Duo/Truelab Quattro
Connect with us
Molbio Diagnostics Limited
(Formerly Molbio Diagnostics Private Limited)
© All Rights Reserved
